| CRTE7A2-01 TCR-T Cell for HPV-16 Positive Advanced Cervical, Anal, or Head and Neck Cancers (NCT05122221) | Corregene Biotechnology Co., Ltd | 2022-07-17 |
| Anal Cancer and/or Precancer Screening: Performance Analysis of the BD Onclarity™ HPV Assay on Anal Specimens (NCT06327568) | European Institute of Oncology | 2022-06-17 |
| Role of Antisecretory Factor in Curative Radiochemotherapy for Anal Carcinoma (NCT05351931) | Uppsala University Hospital | 2022-06-01 |
| Chemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma Patients (NCT05374252) | Sixth Affiliated Hospital, Sun Yat-sen University | 2022-05-07 |
| Tolerance to Immunomodulatory Nutritional Therapy in Oncology Patients Undergoing Chemotherapy and Radiotherapy (NCT07021378) | D'Or Institute for Research and Education | 2022-03-23 |
| Circulating Biomarkers in Patients With Anal Cancer Treated With Induction Chemotherapy (NCT05233540) | Aarhus University Hospital | 2022-01-01 |
| Re-optimization Based Online Adaptive Radiotherapy of Anal Cancer (NCT05438836) | Herlev Hospital | 2022-01-01 |
| PD-1 Blockade Combined With Chemotherapy Followed by Concurrent Immunoradiotherapy for Locally Advanced SCCA Patients (NCT05060471) | Sun Yat-sen University | 2021-10-27 |
| A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers (NCT04708470) | National Cancer Institute (NCI) | 2021-10-05 |
| Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes (NCT04907643) | Cedars-Sinai Medical Center | 2021-10-05 |
| Bone-sparing Chemoradiotherapy for Anal Cancer - DACG-II (NCT05385250) | Karen-Lise Garm Spindler | 2021-08-23 |
| ANCA II - Quality of Life and Functional Outcome in Patients With Anal Cancer (NCT04792892) | Sahlgrenska University Hospital | 2021-08-01 |
| Pencil Beam Proton Therapy for Recurrences in Anal Cancer Patients Previously Treated With Radiotherapy (DACG 5) (NCT05055635) | University of Aarhus | 2021-07-07 |
| Assessment of Patients' Quality of Sexual Life After Anal Cancer Treatment (NCT05109468) | Institut du Cancer de Montpellier - Val d'Aurelle | 2021-06-06 |
| The Registry of Oncology Outcomes Associated With Testing and Treatment (NCT04028479) | Taproot Health | 2021-05-05 |
| RTX-321 Monotherapy in Patients With HPV 16+ Tumors (NCT04672980) | Rubius Therapeutics | 2021-04-08 |
| Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer. (NCT03061435) | Dr. Danielle Vicus | 2021-02-01 |
| A Message Framing Intervention for Increasing Parental Acceptance of Human Papillomavirus Vaccination (NCT03856437) | University of Maryland, College Park | 2021-01-22 |
| A Multilevel Intervention to Improve Timely Cancer Detection and Treatment Initiation (NCT04141449) | Brigham and Women's Hospital | 2020-11-18 |
| Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different Locations (NCT04357873) | UNICANCER | 2020-10-28 |
| Detecting HPV DNA in Anal and Cervical Cancers (NCT04857528) | University of Chicago | 2020-10-06 |
| HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers (NCT04432597) | National Cancer Institute (NCI) | 2020-08-11 |
| Phase 1 Study of Oral TP-1454 (NCT04328740) | Sumitomo Pharma America, Inc. | 2020-07-08 |
| Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies (NCT04287868) | National Cancer Institute (NCI) | 2020-06-09 |
| Deciphering Mechanisms Underlying Cancer Immunogenicity (NCT03958240) | Institut Claudius Regaud | 2020-01-17 |
| The Prevent Anal Cancer Palpation Study (NCT04090060) | Medical College of Wisconsin | 2020-01-17 |
| The Prevent Anal Cancer Self-Swab Study (NCT03489707) | Medical College of Wisconsin | 2020-01-09 |
| Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma. A Multicenter, Randomized, Phase II Trial of the German Anal Cancer Study Group (NCT04230759) | Goethe University | 2020-01-07 |
| Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors (NCT04157985) | Dan Zandberg | 2019-11-15 |
| Intrafractional Vaginal Dilation in Anal Cancer Patients Undergoing Pelvic Radiotherapy (NCT04094454) | Juergen Debus | 2019-10-01 |
| High-Resolution Anoscopy Perceived Discomfort Study (NCT04083053) | Wake Forest University Health Sciences | 2019-09-17 |
| Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors (NCT04234113) | SOTIO Biotech AG | 2019-06-13 |
| Anal Intraepithelial Neoplasia and Anal Squamous Cell Carcinoma (NCT05835960) | Imperial College London | 2019-04-01 |
| Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection (NCT03677960) | Antiva Biosciences | 2018-12-17 |
| Prospective Observational Trial to Evaluate Quality of Life After Definitive Chemoradiation in Patients With Anal Cancer (LANACARE) (NCT03792854) | Ludwig-Maximilians - University of Munich | 2018-12-01 |
| Identification of Predictive Factors for Physiological Hypermetabolism of the Anal Canal in 18F-FDG PET / CT (NCT03506529) | Centre Francois Baclesse | 2018-09-17 |
| A Study of mDCF in Combination or Not With Atezolizumab in Advanced Squamous Cell Anal Carcinoma (NCT03519295) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2018-07-03 |
| M7824 in Subjects With HPV Associated Malignancies (NCT03427411) | National Cancer Institute (NCI) | 2018-02-27 |
| A Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for High-Grade Anal Intraepithelial Neoplasia Using the BARRX™ Anorectal Wand (NCT03302858) | Stephen E. Goldstone | 2017-10-01 |
| Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection (NCT03202992) | Antiva Biosciences | 2017-08-11 |
| Drainage Seton With Flap Versus EAS Preserving Seton in Treatment of Transsphincteric Anal Fistula (NCT03983174) | Mansoura University | 2017-01-01 |
| CaptHPV : Validation of the Method "CaptHPV" for the Diagnosis of Human Papillomavirus Associated Infiltrating Carcinomas (NCT02981862) | Institut de Cancérologie de Lorraine | 2016-12-19 |
| Early Rectal Cancer: Endoscopic Submucosal Dissection or Transanal Endoscopic Microsurgery? (NCT02885142) | Assistance Publique Hopitaux De Marseille | 2016-11-01 |
| Pembrolizumab in Metastatic Anal Cancer (NCT02919969) | Dana-Farber Cancer Institute | 2016-10-11 |
| A Prospective, Open-Label, Multi-center Comparison of Lymphoseek Identified Lymph Nodes and Clinically Identified Lymph Nodes of Subjects With Known Cancer of the Anus (NCT02857608) | Cardinal Health 414, LLC | 2016-09-01 |
| Programs To Support You During Chemotherapy (NCT02489422) | Wake Forest University Health Sciences | 2016-08-01 |
| A Phase 2 Study of Axalimogene Filolisbac (ADXS11-001) in Participants With Carcinoma of the Anorectal Canal (NCT02399813) | Advaxis, Inc. | 2016-06-02 |
| Shared Decision Making With Anal Cancer Patients on Radiation Dose (NCT02785263) | Vejle Hospital | 2016-06-01 |
| PLAN-A Data- Bio- and Plan- Bank Collection for SCCA in Denmark (NCT05570279) | Aarhus University Hospital | 2016-04-01 |
| Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) (NCT02628067) | Merck Sharp & Dohme LLC | 2015-12-18 |
| The HPV-SAVE Study Team: HPV Screening and Vaccine Evaluation in Men Who Have Sex With Men (NCT02503111) | University Health Network, Toronto | 2015-11-01 |
| Prospective Cohort on Quality of Sexual Life Among Men Who Have Sex With Men Treated for Anal Cancer With Concurrent Chemotherapy and Intensity-modulated Radiotherapy (NCT02949596) | Instituto do Cancer do Estado de São Paulo | 2015-10-01 |
| Multimodal Monitoring of Radiotherapy Response in Squamous Cell Cancer (NCT02379039) | Umeå University | 2015-05-01 |
| ART: Anal Squamous Cell Carcinoma: Investigation of Functional Imaging During chemoRadioTherapy (NCT02145416) | University of Oxford | 2015-01-27 |
| E6/E7 mRNA Performance to Detect HSIL and Cost-effectiveness Analysis of This Screening Strategy in HIV + MSM (NCT03357991) | Hospital Universitari de Bellvitge | 2015-01-11 |
| Individual Following in Anal Cancer With PET/CT (NCT02697084) | Centre Antoine Lacassagne | 2014-11-01 |
| T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers (NCT02280811) | National Cancer Institute (NCI) | 2014-10-14 |
| Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Lesions (NCT02135419) | AIDS Malignancy Consortium | 2014-09-24 |
| Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIV (NCT01946139) | AIDS Malignancy Consortium | 2013-12-04 |
| Integrated Cancer Repository for Cancer Research (NCT02012699) | University of Nebraska | 2013-11-01 |
| Anal Cancer Radiotherapy Study (NCT01937780) | Oslo University Hospital | 2013-10-04 |
| Functional Outcomes Following Anal Cancer Treatment (NCT01853059) | Cambridge University Hospitals NHS Foundation Trust | 2013-10-01 |
| A Phase I/II Evaluation of ADXS11-001, Mitomycin, 5-fluorouracil (5-FU) and IMRT for Anal Cancer (NCT01671488) | Brown University | 2013-02-01 |
| Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003) (NCT01651949) | Merck Sharp & Dohme LLC | 2012-10-29 |
| Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associated Cancers (NCT01585428) | National Cancer Institute (NCI) | 2012-04-13 |
| Assessment of New Radiation Oncology Technologies and Treatments (NCT01379872) | Trans Tasman Radiation Oncology Group | 2011-06-01 |
| Infrared Coagulator Ablation or Observation in Preventing Anal Cancer in HIV-Positive Patients With Anal Neoplasia (NCT01164722) | AIDS Malignancy Consortium | 2011-04-01 |
| Topical MTS-01 for Dermatitis During Radiation and Chemotherapy for Anal Cancer (NCT01324141) | National Cancer Institute (NCI) | 2011-03-18 |
| Predictive Value of FMISO-PET, FDG-PET-CT, DWI-MRI and DCE-MRI Scans for Patients With Anal Cancer Receiving Radiotherapy +/- Chemotherapy (NCT01330186) | Copenhagen University Hospital at Herlev | 2011-02-01 |
| Cancer in Patients With Gabapentin (GPRD) (NCT01236053) | GlaxoSmithKline | 2010-06-01 |
| Hybrid Capture 2 Human Papiloma Virus (HPV) High-Risk Anal DNA Test (NCT01104181) | Laser Surgery Care | 2010-03-01 |
| Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers (NCT01031056) | Stanford University | 2010-01-01 |
| Low-Fiber Diet or High-Fiber Diet in Preventing Bowel Side Effects in Patients Undergoing Radiation Therapy for Gynecological Cancer, Bladder Cancer, Colorectal Cancer, or Anal Cancer (NCT01170299) | Royal Marsden NHS Foundation Trust | 2009-10-01 |
| Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer (NCT00903396) | Alliance for Clinical Trials in Oncology | 2009-09-01 |
| Anal Cancer Screening Study (NCT00914537) | National Cancer Institute (NCI) | 2009-06-02 |
| Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer (NCT01526486) | Emory University | 2009-06-01 |
| Comparing Two Types of Swabs in Collecting Cell Samples for Anal Pap Tests and Human Papillomavirus Tests in Men Who Have Sex With Men (NCT00955591) | Jonsson Comprehensive Cancer Center | 2009-03-12 |
| Radiation Therapy, Cisplatin, Fluorouracil, and Cetuximab in Treating Patients With Locally Advanced Anal Cancer (NCT00955240) | UNICANCER | 2009-03-01 |
| Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer (NCT00836992) | Mayo Clinic | 2009-01-01 |
| Study of Vaginal Dilator Use After Pelvic Radiotherapy (NCT00789893) | Memorial Sloan Kettering Cancer Center | 2008-11-01 |
| B-Receptor Signaling in Cardiomyopathy (NCT01135849) | Daniel Bernstein | 2008-11-01 |
| Permission to Collect Blood Over Time for Research (NCT00767234) | Stanford University | 2008-08-01 |
| Pilot Study to Determine the Safety and Efficacy of Gardasil Against the Human Papilloma Virus (HPV) in HIV-infected Men (NCT00666107) | Southern California Institute for Research and Education | 2008-06-01 |
| Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer (NCT00654160) | Mayo Clinic | 2008-06-01 |
| Avastin/[18-F]-5-fluorouracil PET/CT Imaging Feasibility Project (NCT00661154) | Stanford University | 2008-02-01 |
| Cidofovir in Treating HIV-Infected Patients With High-Grade Squamous Intraepithelial Lesions of the Skin Near the Anus (NCT00550589) | AIDS Malignancy Consortium | 2007-09-01 |
| Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy (NCT00896467) | Centre Oscar Lambret | 2007-09-01 |
| Radiation Dosimetry Study Comparing 2 Different Patient Setups in Anal/Rectal Cancer Patients (NCT00693173) | The University of Texas Medical Branch, Galveston | 2007-07-01 |
| Assessing Drivers and Barriers to Follow-Up Screening for Anal Cancer in Men Who Have Sex With Men (NCT00501306) | Laser Surgery Care | 2007-06-01 |
| Cetuximab, Cisplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Anal Cancer (NCT00316888) | ECOG-ACRIN Cancer Research Group | 2007-02-28 |
| Intensity-Modulated Radiation Therapy, Fluorouracil, and Mitomycin C in Treating Patients With Invasive Anal Cancer (NCT00423293) | Radiation Therapy Oncology Group | 2006-12-01 |
| Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer (NCT00324415) | AIDS Malignancy Consortium | 2006-09-01 |
| Image Fusion PET, CT and 3D-ultrasound Examinations (NCT00302094) | Rigshospitalet, Denmark | 2006-06-01 |
| QOL & Functional Outcomes After Combined Modality Tx for Anal CA: Comparison of Conventional vs IMRT (NCT00568425) | Stanford University | 2005-09-01 |
| Molecular Genetic and Pathological Studies of Anal Tumors (NCT00267787) | Stanford University | 2004-09-01 |
| Chemoradiation-Induced Nausea and Emesis: Quality of Life (NCT00394602) | M.D. Anderson Cancer Center | 2004-04-07 |
| Capecitabine, Oxaliplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer (NCT00093379) | M.D. Anderson Cancer Center | 2004-04-01 |
| Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer (NCT00075868) | Radiation Therapy Oncology Group | 2003-12-01 |
| Assessment of Health Related Quality of Life in Patients Treated for Rectal Cancer (NCT00532987) | Stanford University | 2003-12-01 |
| Infrared Coagulation in Preventing Anal Cancer in Patients With HIV Who Have Anal Neoplasia (NCT00066430) | AIDS Malignancy Consortium | 2003-09-01 |